These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30169613)

  • 1. Research partnerships between Coca-Cola and health organizations in Spain.
    Rey-López JP; Gonzalez CA
    Eur J Public Health; 2019 Oct; 29(5):810-815. PubMed ID: 30169613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Always read the small print": a case study of commercial research funding, disclosure and agreements with Coca-Cola.
    Steele S; Ruskin G; McKee M; Stuckler D
    J Public Health Policy; 2019 Sep; 40(3):273-285. PubMed ID: 31065042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coca-Cola - a model of transparency in research partnerships? A network analysis of Coca-Cola's research funding (2008-2016).
    Serôdio PM; McKee M; Stuckler D
    Public Health Nutr; 2018 Jun; 21(9):1594-1607. PubMed ID: 29560842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Public Meets Private: Conversations Between Coca-Cola and the CDC.
    Maani Hessari N; Ruskin G; McKEE M; Stuckler D
    Milbank Q; 2019 Mar; 97(1):74-90. PubMed ID: 30693564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Big food and drink sponsorship of conferences and speakers: a case study of one multinational company's influence over knowledge dissemination and professional engagement.
    Atli Gunnarsson J; Ruskin G; Stuckler D; Steele S
    Public Health Nutr; 2023 May; 26(5):1094-1111. PubMed ID: 36450363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating Coca-Cola's attempts to influence public health 'in their own words': analysis of Coca-Cola emails with public health academics leading the Global Energy Balance Network.
    Serodio P; Ruskin G; McKee M; Stuckler D
    Public Health Nutr; 2020 Oct; 23(14):2647-2653. PubMed ID: 32744984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complexity and conflicts of interest statements: a case-study of emails exchanged between Coca-Cola and the principal investigators of the International Study of Childhood Obesity, Lifestyle and the Environment (ISCOLE).
    Stuckler D; Ruskin G; McKee M
    J Public Health Policy; 2018 Feb; 39(1):49-56. PubMed ID: 29180754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Food industry sponsorship of academic research: investigating commercial bias in the research agenda.
    Fabbri A; Holland TJ; Bero LA
    Public Health Nutr; 2018 Dec; 21(18):3422-3430. PubMed ID: 30157979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Science organisations and Coca-Cola's 'war' with the public health community: insights from an internal industry document.
    Barlow P; Serôdio P; Ruskin G; McKee M; Stuckler D
    J Epidemiol Community Health; 2018 Sep; 72(9):761-763. PubMed ID: 29540465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies used by the soft drink industry to grow and sustain sales: a case-study of The Coca-Cola Company in East Asia.
    Huse O; Reeve E; Bell C; Sacks G; Baker P; Wood B; Backholer K
    BMJ Glob Health; 2022 Dec; 7(12):. PubMed ID: 36593644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soda industry influence on obesity science and policy in China.
    Greenhalgh S
    J Public Health Policy; 2019 Mar; 40(1):5-16. PubMed ID: 30626895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myths and morality at Coca-Cola.
    Lancet; 2009 Apr; 373(9671):1224. PubMed ID: 19362655
    [No Abstract]   [Full Text] [Related]  

  • 13. Sponsorship of National Health Organizations by Two Major Soda Companies.
    Aaron DG; Siegel MB
    Am J Prev Med; 2017 Jan; 52(1):20-30. PubMed ID: 27745783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inside ILSI: How Coca-Cola, Working through Its Scientific Nonprofit, Created a Global Science of Exercise for Obesity and Got It Embedded in Chinese Policy (1995-2015).
    Greenhalgh S
    J Health Polit Policy Law; 2021 Apr; 46(2):235-276. PubMed ID: 32955566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coca-Cola's funding of health research and partnerships.
    The Lancet
    Lancet; 2015 Oct; 386(10001):1312. PubMed ID: 26460760
    [No Abstract]   [Full Text] [Related]  

  • 16. How Coca-Cola Shaped the International Congress on Physical Activity and Public Health: An Analysis of Email Exchanges between 2012 and 2014.
    Wood B; Ruskin G; Sacks G
    Int J Environ Res Public Health; 2020 Dec; 17(23):. PubMed ID: 33287097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of an acidic beverage (Coca-Cola) on the pharmacokinetics of carbamazepine in healthy volunteers.
    Malhotra S; Dixit RK; Garg SK
    Methods Find Exp Clin Pharmacol; 2002; 24(1):31-3. PubMed ID: 11980385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corporate sponsorship of physical activity promotion programmes: part of the solution or part of the problem?
    Jane B; Gibson K
    J Public Health (Oxf); 2018 Jun; 40(2):279-288. PubMed ID: 28591792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of an acidic beverage (Coca-Cola) on the pharmacokinetics of phenytoin in healthy rabbits.
    Kondal A; Garg SK
    Methods Find Exp Clin Pharmacol; 2003 Dec; 25(10):823-5. PubMed ID: 14735231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disclosures of Coca-Cola funding: transparent or opaque?
    Tseng M; Barnoya J; Kruger S; Lachat C; Vandevijvere S; Villamor E
    Public Health Nutr; 2018 Jun; 21(9):1591-1593. PubMed ID: 29560846
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.